Joanna Wiensch
Stock Analyst at Citigroup
(2.41)
# 2,288
Out of 5,182 analysts
32
Total ratings
65.22%
Success rate
6.52%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Buy | $232 → $198 | $158.54 | +24.89% | 9 | Feb 11, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $96.81 | +31.18% | 8 | Aug 22, 2024 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $63.98 | +41.06% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $70.06 | +13.47% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Holdings | Initiates: Buy | $120 | $125.32 | -4.25% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $332.13 | -39.78% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $124.79 | -67.95% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $94.78 | +77.25% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $81.32 | -22.53% | 1 | Mar 5, 2020 | |
| SYK Stryker | Initiates: Buy | $235 | $343.32 | -31.55% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $203.73 | +7.99% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $80.99 | +3.72% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $18.71 | +402.41% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $234.18 | -30.40% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $86.19 | +43.87% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
Feb 11, 2026
Maintains: Buy
Price Target: $232 → $198
Current: $158.54
Upside: +24.89%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $96.81
Upside: +31.18%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $63.98
Upside: +41.06%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $70.06
Upside: +13.47%
iRhythm Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $125.32
Upside: -4.25%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $332.13
Upside: -39.78%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $124.79
Upside: -67.95%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $94.78
Upside: +77.25%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $81.32
Upside: -22.53%
Stryker
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $343.32
Upside: -31.55%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $203.73
Upside: +7.99%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $80.99
Upside: +3.72%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $18.71
Upside: +402.41%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $234.18
Upside: -30.40%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $86.19
Upside: +43.87%